You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mAb

Showing 1 - 25 of 1,029
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Respiratory Distress Syndrome (ARDS) Trial (ALT-100 mAb, ALT-100 (Placebo))

Not yet recruiting
  • Acute Respiratory Distress Syndrome (ARDS)
  • ALT-100 mAb
  • ALT-100 (Placebo)
  • (no location specified)
Jul 7, 2023

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

Not yet recruiting
  • Hepatitis b Virus
  • HepB mAb19
  • Sterile Saline
  • New York, New York
  • +1 more
May 12, 2023

Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

Active, not recruiting
  • Pyoderma
  • +3 more
  • Monoclonal antibody (Mab) sB24M
  • Minsk, Belarus
  • +1 more
Jul 8, 2022

Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival Trial in Wuhan (Surufatinib)

Recruiting
  • Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
Mar 8, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-MAB)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jan 24, 2022

Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • CHF10067 starting dose
  • +3 more
  • (no location specified)
Aug 22, 2022

Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Endostatin
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022

Hemorrhagic Fever, Ebola Trial in Congo, The Democratic Republic of the, Sierra Leone (Ansuvimab)

Available
  • Hemorrhagic Fever, Ebola
  • Mbandaka, Equateur, Congo, The Democratic Republic of the
  • +3 more
May 3, 2022

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Migraine Trial in Los Angeles, Newport Beach, Waterbury (Galcanezumab, Erenumab)

Completed
Has Results
  • Migraine
  • Los Angeles, California
  • +2 more
Feb 23, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

B-cell Lymphoid Malignancies Trial (ESG206)

Not yet recruiting
  • B-cell Lymphoid Malignancies
  • (no location specified)
Apr 10, 2023

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022

Melanoma, Pancreatic Ductal Adenocarcinoma Trial in Richmond (YH003, Toripalimab, Nab-paclitaxel)

Recruiting
  • Melanoma
  • Pancreatic Ductal Adenocarcinoma
  • Richmond, Victoria, Australia
    Epworth Medical Centre
Dec 22, 2021

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Advanced Solid Tumors Trial in Nedlands (YH003, Toripalimab, Nab-paclitaxel)

Active, not recruiting
  • Advanced Solid Tumors
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Dec 29, 2021

Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural

Not yet recruiting
  • Rabies Virus Infection
  • Natural full human monoclonal antibody CBB 1 injection
  • +3 more
  • Kunming, Yunnan, China
    The First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Experimental: Stage 1L: HLX10 Plus HLX07, Experimental: Stage 1H: HLX10

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Experimental: Stage 1L: HLX10 Plus HLX07
  • Experimental: Stage 1H: HLX10 Plus HLX07
  • Shanghai, Shanghai, China
    Shanghai Henlius Biotech Inc.
May 5, 2022

Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)

Not yet recruiting
  • Atopic Dermatitis
  • Newark, Delaware
    Biosion USA, Inc.
Jul 7, 2023

Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor, Adult
  • Hackensack, New Jersey
  • +3 more
Apr 14, 2022

Healthy Volunteers Trial in Hannover (CSL324, Placebo)

Recruiting
  • Healthy Volunteers
  • Hannover, Germany
    Fraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023

Advanced Solid Tumors Trial in Beijing, Shanghai (JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection))

Recruiting
  • Advanced Solid Tumors
  • JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection)
  • Beijing, Beijing, China
  • +2 more
Apr 1, 2022

Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

Completed
  • Rheumatoid Arthritis
  • IL-6R Monoclonal Antibody Injection 4mg/kg
  • +3 more
  • Baoding, China
  • +4 more
Feb 24, 2022